Halozyme elects James Lang to Board of Directors, term through 2027 annual meeting

HALOZYME THERAPEUTICS, INC.

James Lang elected to Halozyme's Board on December 4, 2025.
Mr. Lang's term expires at the 2027 annual meeting of stockholders.
No Board committee assignments initially made.
Compensation follows standard non-employee director program as described in the 2025 proxy.
No related party transactions or arrangements exist with Mr. Lang.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.